Navigation Links
Accuray Hires Chief Marketing Officer
Date:1/18/2011

he benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas.  To date, the CyberKnife System has been used to treat more than 100,000 patients worldwide and currently more than 215 systems have been installed in leading hospitals in the Americas, Europe and Asia.  For more information, please visit www.accuray.com.

Safe Harbor Statement

The foregoing may contain certain forward-looking statements that involve risks and uncertainties, including uncertainties associated with the medical device industry.  Except for the historical information contained herein, the matters set forth in this press release, including statements relating to qualitative management experience and market acceptance are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements speak only as of the date the statements are made and are based on information available at the time those statements are made and/or management's good faith belief as of that time with respect to future events.  You should not put undue reliance on any forward-looking statements.  Important factors that could cause actual performance and results to differ materially from the forward-looking statements we make include: market acceptance of products; competing products, the combination of our products with complementary technology; and other risks detailed from time to time under the heading "Risk Factors" in our report on Form 10-K for our 2010 fiscal year, our form 10-Q filed on November 8, 2010 and our other filings with the Securities and Exchange Commission.  The Company's actual results of operations may differ significantly from those contemplated by such forward-looking statements as a result of these and other factors.  We assume no obligation to u
'/>"/>

SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2010
2. Accuray Incorporated to Present at 20th Annual Oppenheimer Healthcare Conference
3. Accuray Ranked 155th Fastest Growing Company in North America on Deloittes 2009 Technology Fast 500(TM)
4. Accuray Announces Regionalized Management Strategy for Americas
5. Accurays Treatment Planning Service Active at 20 Percent of U.S. CyberKnife Centers
6. Accuray Introduces the CyberKnife(R) VSI(TM) System
7. Accuray Announces Results for Second Quarter Fiscal 2010
8. Accuray Incorporated to Report Financial Results for Second Quarter of Fiscal 2010
9. Accuray Hires General Manager for Japan
10. Accuray Incorporated to Present at 28th Annual J. P. Morgan Healthcare Conference
11. Accuray Incorporated to Present at Piper Jaffray Healthcare Conference and J. P. Morgan Small/Mid Cap Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... LONDON , March 26, 2015 ... release, please scroll to bottom . Investor-Edge ... (NASDAQ: MYL ), Salix Pharmaceuticals Ltd (NASDAQ: ... Inc. (NASDAQ: VVUS ), and Akorn Inc. (NASDAQ: ... be accessed at http://get.Investor-Edge.com/pdf/?c=Mylan&d=26-Mar-2015&s=MYL . The US markets ...
(Date:3/26/2015)... , Kalifornien, 26. März 2015 ... 2015, die sich speziell an Innovatoren, Visionäre ... Die zweitägige Konferenz für geladene ... 2015 im Hyatt Regency in ... diesem Forum werden führende Akteure der Biowissenschaften ...
(Date:3/26/2015)... de março de 2015 A Finesse Solutions ... projetado especificamente para os inovadores, visionários e executivos seniores ... apenas por convite, será realizada no Hyatt Regency em ... e 22 de setembro de 2015. Será um fórum ... futuro da fabricação de produtos biofarmacêuticos de uso único ...
Breaking Medicine Technology:Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 2Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 3Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 4Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 5Finesse Solutions kündigt Cellworld 2015 an 2Finesse Solutions anuncia Cellworld 2015 2
... For the second year in a row the New York Yankees ... Hearing Foundation deliver the gift of hearing to more than ... The Starkey Hearing Foundation New York Yankees Hearing Mission was held ... New York Yankees Pitcher CC Sabathia, Manager Joe Girardi and ...
... 2011 In strong collaboration with clinical research partners, ... of the LokomatPro that offers greater system capabilities. Since ... 2001, the LokomatPro has established itself as an effective ... neurological diseases and injuries resulting in gait impairment. ...
Cached Medicine Technology:New York Yankees Help Starkey Hearing Foundation Deliver the Gift of Hearing to New York Area Children and Adults in Need 2New York Yankees Help Starkey Hearing Foundation Deliver the Gift of Hearing to New York Area Children and Adults in Need 3Hocoma Launches New Version of its Established Gait Training Device LokomatPro 2
(Date:3/26/2015)... York (PRWEB) March 26, 2015 ... move forward nationwide, with the issuance of new ... Pennsylvania and Louisiana. According to an Order dated ... litigation established for Xarelto injury claims in the ... now allow plaintiffs to file cases directly in ...
(Date:3/26/2015)... “The SWEET Act is an important step to invigorate ... help parents who are working to reduce sugar in their ... support public health, and we will continue to stand on ... all families,” said Dr. Jane Delgado President and CEO of ... the Sugar-Sweetened Beverage Tax (SWEET) Act by Congresswoman Rosa L. ...
(Date:3/26/2015)... March 26, 2015 Dr. Alex Rabinovich ... to announce expanded offerings for Bay Area patients considering ... Implant Center has long been a top-rated center, serving ... offerings to meet the strong demand by others throughout ... as a top-rated dental implant facility in San Francisco,”explained ...
(Date:3/26/2015)... Springs, FL (PRWEB) March 26, 2015 ... of the nation’s leading innovative specialty pharmacies, announces ... created position of Vice President of Pharmaceutical Relations. ... fostering beneficial connections with our pharmaceuticals partners and ... relationships in support of BioPlus’ expansion. , ...
(Date:3/26/2015)... UK (PRWEB) March 26, 2015 In the ... billion as of 2013 and is set to decrease through ... by 2020; the growth is expected up to 2017 at ... is expected to be owing to the surging penetration of ... HCT, Twynsta, Micardis Plus, Valturna, Benicar HCT, and Tekamlo), a ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 3Health News:National Alliance for Hispanic Health Statement on Introduction of SWEET Act in 114th Congress 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 3Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 3
... , ... Disease Foundation (VDF) is seeking nominations for the 2010 President’s Awards, which recognize those ... disease or have assisted the Foundation in accomplishing its mission in various categories. The ... ...
... ... this health observance day, VIP Smiles, owned by celebrity dentist Dr. Catrise Austin ... Street location by appointment from June 21st - June 28th, 2010. VIP Smiles ... offer the OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test, which can be administered orally ...
... By combining two relatively inexpensive technologies based on sound and ... women undergo breast biopsies for suspicious lesions. Results of the ... edition and the August print issue of Radiology . ... the potential of diffuse optical tomography in the near infrared ...
... realize international health goals aiming to improve maternal health, ... is crucial. In an editorial published this week entitled ... editors argue that action on maternal health must ... much as it does access to basic medical care. ...
... appendages such as hair, nails, sweat glands and mammary ... the United States, according to a report in the ... of the JAMA/Archives journals. "Cutaneous appendageal carcinomas are ... diverse differentiation that frequently present a diagnostic challenge," the ...
... A new study in the journal Respirology ... acute exacerbations of chronic obstructive pulmonary disease (COPD) experience ... an increased risk of death, compared to those without ... due to impairment of immune responses. Researchers led by ...
Cached Medicine News:Health News:Nominations Wanted for Vascular Disease Foundation President's Awards 2Health News:June 27th Is National HIV Testing Day-New York Celebrity Dentist Offers Free Oral Rapid HIV Testing In the Dental Office 2Health News:June 27th Is National HIV Testing Day-New York Celebrity Dentist Offers Free Oral Rapid HIV Testing In the Dental Office 3Health News:Noninvasive combination technique may reduce number of breast biopsies 2Health News:Cancers of sweat glands, other skin-related structures may be increasing in United States 2
... Mosaic, the third generation tissue valve ... stented tissue valve available. The Mosaic valve ... experience and is an excellent choice for ... replacement with a tissue valve. For more ...
... bioprosthesis from Medtronic has more ... clinical experience. Worldwide clinical studies ... structural valve deterioration with Hancock® ... is substantially better than results ...
... The Hancock® II bioprosthesis ... 15 years of proven clinical ... that the freedom from structural ... aortic and mitral bioprostheses is ...
Attain Venogram Balloon Catheter....
Medicine Products: